CD274 and sarcoma: D’Angelo et al. assessed programmed death ligand 1 (PD-L1) expression in 50 heterogeneous sarcoma samples using IHC and identified PD-L1 expression in only 12% of cases, but tumor infiltrating lymphocytes were present in 98% of samples [51].